These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29564682)

  • 1. Opioid Exposure is Associated with Aberrant DNA Methylation of OPRM1 Promoter Region in a Chinese Han Population.
    Xu J; Wang T; Su Z; Zhou X; Xiang Y; He L; Li C; Yang Z; Zhao X
    Biochem Genet; 2018 Oct; 56(5):451-458. PubMed ID: 29564682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts.
    Chorbov VM; Todorov AA; Lynskey MT; Cicero TJ
    J Opioid Manag; 2011; 7(4):258-64. PubMed ID: 21957825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts.
    Nielsen DA; Yuferov V; Hamon S; Jackson C; Ho A; Ott J; Kreek MJ
    Neuropsychopharmacology; 2009 Mar; 34(4):867-73. PubMed ID: 18650805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts.
    Nielsen DA; Hamon S; Yuferov V; Jackson C; Ho A; Ott J; Kreek MJ
    Hum Genet; 2010 Jun; 127(6):639-49. PubMed ID: 20237803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter.
    Sandoval-Sierra JV; Salgado García FI; Brooks JH; Derefinko KJ; Mozhui K
    Clin Epigenetics; 2020 Jun; 12(1):76. PubMed ID: 32493461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder.
    Ebrahimi G; Asadikaram G; Akbari H; Nematollahi MH; Abolhassani M; Shahabinejad G; Khodadadnejad L; Hashemi M
    Am J Drug Alcohol Abuse; 2018; 44(2):193-199. PubMed ID: 28121474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence.
    Zhang H; Herman AI; Kranzler HR; Anton RF; Simen AA; Gelernter J
    J Hum Genet; 2012 Oct; 57(10):670-5. PubMed ID: 22914673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the
    Liu L; Yang X; Zhao F; Gao C; Zhang N; Bao J; Li K; Zhang X; Lu X; Ruan Y; Zhong S
    Am J Drug Alcohol Abuse; 2021 Nov; 47(6):694-703. PubMed ID: 34582308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads.
    Wachman EM; Hayes MJ; Shrestha H; Nikita FNU; Nolin A; Hoyo L; Daigle K; Jones HE; Nielsen DA
    Genes Brain Behav; 2018 Sep; 17(7):e12476. PubMed ID: 29575474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain.
    Doehring A; Oertel BG; Sittl R; Lötsch J
    Pain; 2013 Jan; 154(1):15-23. PubMed ID: 23273101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of OPRK1 and OPRM1 methylation with mild cognitive impairment in Xinjiang Han and Uygur populations.
    Liu G; Ji H; Liu J; Xu C; Chang L; Cui W; Ye C; Hu H; Chen Y; Zhou X; Duan S; Wang Q
    Neurosci Lett; 2017 Jan; 636():170-176. PubMed ID: 27838450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic-epigenetic interaction modulates μ-opioid receptor regulation.
    Oertel BG; Doehring A; Roskam B; Kettner M; Hackmann N; Ferreirós N; Schmidt PH; Lötsch J
    Hum Mol Genet; 2012 Nov; 21(21):4751-60. PubMed ID: 22875838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic and sex differences in opioid use disorder in chronic pain: A real-world study linked with OPRM1 DNA methylation.
    Agulló L; Escorial M; Orutño S; Muriel J; Sandoval J; Margarit C; Peiró AM
    Addict Biol; 2024 Jul; 29(7):e13422. PubMed ID: 38949208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease.
    Xu C; Liu G; Ji H; Chen W; Dai D; Chen Z; Zhou D; Xu L; Hu H; Cui W; Chang L; Zha Q; Li L; Duan S; Wang Q
    Mol Med Rep; 2018 Nov; 18(5):4297-4302. PubMed ID: 30152845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence.
    Lin Y; Kranzler HR; Farrer LA; Xu H; Henderson DC; Zhang H
    Pharmacogenomics J; 2020 Oct; 20(5):672-680. PubMed ID: 32029903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin.
    Shi J; Hui L; Xu Y; Wang F; Huang W; Hu G
    Hum Mutat; 2002 Apr; 19(4):459-60. PubMed ID: 11933204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome.
    Wachman EM; Hayes MJ; Lester BM; Terrin N; Brown MS; Nielsen DA; Davis JM
    J Pediatr; 2014 Sep; 165(3):472-8. PubMed ID: 24996986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation in the promoter region of the ADRA1A gene is associated with opioid use disorder in Han Chinese.
    Zhang J; Fu X; Lu Y; Cheng C; Wang K; Zhu Y; Xie Q
    Brain Res; 2022 Oct; 1793():148050. PubMed ID: 35964682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoepigenetics of the role of DNA methylation in μ-opioid receptor expression in different human brain regions.
    Knothe C; Oertel BG; Ultsch A; Kettner M; Schmidt PH; Wunder C; Toennes SW; Geisslinger G; Lötsch J
    Epigenomics; 2016 Dec; 8(12):1583-1599. PubMed ID: 27685027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.
    Haerian BS; Haerian MS
    Pharmacogenomics; 2013 May; 14(7):813-24. PubMed ID: 23651028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.